Ascendis Pharma A/S (ASND)
223.25
-3.75
(-1.65%)
USD |
NASDAQ |
Oct 13, 16:00
223.25
0.00 (0.00%)
After-Hours: 20:00
Ascendis Pharma Total Return Level : 227.00 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 227.00 |
| October 09, 2026 | 229.23 |
| October 08, 2026 | 222.69 |
| October 07, 2026 | 228.41 |
| October 06, 2026 | 226.05 |
| October 05, 2026 | 228.03 |
| October 02, 2026 | 227.87 |
| October 01, 2026 | 227.31 |
| September 30, 2026 | 227.83 |
| September 29, 2026 | 228.07 |
| September 28, 2026 | 230.05 |
| September 25, 2026 | 225.60 |
| September 24, 2026 | 230.70 |
| September 23, 2026 | 223.13 |
| September 22, 2026 | 237.57 |
| September 21, 2026 | 237.59 |
| September 18, 2026 | 236.72 |
| September 17, 2026 | 239.04 |
| September 16, 2026 | 247.69 |
| September 15, 2026 | 239.77 |
| September 14, 2026 | 264.92 |
| September 11, 2026 | 263.52 |
| September 10, 2026 | 261.23 |
| September 09, 2026 | 260.81 |
| September 08, 2026 | 270.09 |
| Date | Value |
|---|---|
| September 04, 2026 | 270.56 |
| September 03, 2026 | 271.12 |
| September 02, 2026 | 267.31 |
| September 01, 2026 | 260.25 |
| August 31, 2026 | 263.04 |
| August 28, 2026 | 247.91 |
| August 27, 2026 | 249.36 |
| August 26, 2026 | 250.25 |
| August 25, 2026 | 252.99 |
| August 24, 2026 | 251.95 |
| August 21, 2026 | 253.29 |
| August 20, 2026 | 254.81 |
| August 19, 2026 | 259.62 |
| August 18, 2026 | 248.85 |
| August 17, 2026 | 247.40 |
| August 14, 2026 | 248.50 |
| August 13, 2026 | 246.23 |
| August 12, 2026 | 255.46 |
| August 11, 2026 | 254.57 |
| August 10, 2026 | 255.62 |
| August 07, 2026 | 255.41 |
| August 06, 2026 | 249.85 |
| August 05, 2026 | 244.20 |
| August 04, 2026 | 244.59 |
| August 03, 2026 | 243.45 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| BioMarin Pharmaceutical, Inc. | 55.39 |
| Novo Nordisk A/S | 69.04 |
| Evaxion AS | 3.00 |
| Genmab A/S | 37.37 |
| Zealand Pharma A/S | 34.86 |